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PREFACE
Recently, the author had the opportunity to become
involved in research in the micronutrient metabolism of
plants.

The interrelations of micronutrient metabolism

in regard to plant nutrition, growth, and reproduction,
was a f.ocal point.

Although other micronutrients were

studied, the primary emphasis was placed upon zinc and its
role in plant growth.
It has been successfully shown that zinc does play
a very essential role in plant growth.

Since many plant

and animal enzyme systems are essentially the same, the importance of zinc in the human body in relation to growth,
function, and the welfare of man, presents unanswered questions .to me.

Among the questions one must examine in

studying any micronutrient, are; (1) is the element found
in the body, if so, where, and in what proportions?

(2)

How is the element involved in humans and just what is its
importance in human metabolic systems?
played in human disease?

(3) What role is

(4) How can the element be used

to alleviate human suffering?
I propose to answer these questions with respect to
zinc in an effort to reach some conclusions on the importance
of this element in human metabolism,
I wish to acknowledge and thank Doctor Paul Hodgson
for his help and assistance in the preparation of this thesis,
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CHAPTER I
INTRODUCTION

Since man began, he has been vitally interested in
the effects of the substances which make up his environment upon his body.

Initially, man was interested in food

or potential food substances.

He was concerned whether ex-

cesses or deficiencies of these substances had any influence
on his he,alth.

Later, man became aware that disease pro-

cesses could be related to a variety of identifiable causes
in which nutrition played a role, and during the past forty
to fifty years, intense study of the mechanisms of dise,ases
was focused on the effects of excesses or deficiencies of
the basic substances, such as mineral elements, vitamins,
harmones, and enzymes.
The research in zinc metabolism has roughly paralleled man's quest.
The presence of zinc in muscles and liver was first
discovered in 1877 (79).

However, the need for zinc in human

nutrition was actually demonstrated only recently.
Early indications for a biologic function for zinc
may be given by citation of the early literature on the
effects of zinc; Raulin, in 1869, proved zinc was a necessary nutrient to Aspergillus niger (80).

Mendel and Bradley

in 1906, produced evidence that zinc was an essential constituent of the respiratory pigment of the snail, Sycotypus,
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analogous to the hemocyanins (56).

In 1919, Delezene re-

ported a very high concentration of zinc in snake venom,
and then showed it to be in a stable combination with the
intensity of the venom action directly proportional to the
concentration of zinc (13).

Conclusive evidence of the

essential nature of zinc in the rat diet was produced in

1934 by Todd and co-workers (94).
Although conclusive evidence of the zinc requirement
for man and higher animals was not proven until recently,
Keilin and Mann in 1939, showed zinc to be present in the
prosthetic group. of the enzyme carbonic anhydrase and suggested tha

zinc. must be required in nutrition because of

the wide p

of carbonic anhydrase in many animal

species (4 ).
CHAPTER

II

ZI C IN BODY TISSUES, ORGANS, AND FLUIDS
1.

Whole Body

The total body zinc stores in the average adult human
ranges between 1.2 and 3 grams.

This is about one half the

biologic store of iron, 10-15 times the store of copper and
40 times th t of iodine.

The amount of zinc supplied by an

average daily diet is approximately 10-15 mg, but, as is the
case of most orally ingested substances, the fraction actually absorbed from the intestinal tract is influenced by
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numerous physiologic mechanisms (96, 48, 103).
Apparently, there is little. if any, evidence of
appreciable storage of zinc by the fetus, as occurs with
iron and copper.

The concentration of zinc in the human

fetus changes little throughout fetal life and the liver
and spleen together always contain approximately the same
proportion (roughly one-quarter) of the tota.l zinc (Ill).
Newborn and very young mammals seem to be more variable than adults in zinc content and tend to contain somewhat lower, or similar, concentrations of the element at
birth and ma turi ty.

However, the value.s given in the

literature for some newborn animals (cat, guinea pig, rabbit)
may be abnormally high if one considers the increased amount
of hair on these animals in comparison to mouse, rat, and
human values.

Hair and fur contain much higher concentra-

tions of zinc than almost all other body tissues.
The normal range of zinc concentration in the human
body has been estimated by various authors to be 15 to 60.
parts per million and depending upon the method used, various
values may be quoted for zinc content of a particular tissue.
The ubiquitous nature of zinc, in addition to the relatively
insensitive methods of zinc analysis up until recent years,
has probably accounted for this great variation o.f quanti tative values seen for zinc levels in tissues.
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2.

Tissue Distribution

Isotopic zinc studies seem to demonstrate a continual
tissue deposition and turnover of zinc which varies greatly
with different tissues.

Zinc-65 injected into the body has

the highest turnover rate in pancreas, liver, kidney, pituitary, and adrenal glands.

Muscle, erythrocytes. brain and

testes exchange zinc less rapidly, whereas zinc is deposited
in the skeleton and teeth relatively slowly, but, found for
relatively long periods of time.

Zinc deposited in hair

remains there until the hair is shed.
In terms of absolute. concentrations, the pigmented
tissues of the eyes, hair. and bones " carry far higher concentrations of zinc than other body tissues and organs.

3.

Eye Structures

Tissues of the eye contain large quantities of zinc.
Vallee has compiled a large number of references into a
survey of species of vertebrates which no only indicates
marked species differences. but marked differences in the
zinc distribution within a single eye (l03).

The zinc con-

tent of lens and aqueous humor is not remarkable in any
species, but the choroid and. retina seem to have outstandingly high values in most cases.

Probably the highest known

concentration of zinc in living matter occurs in the melaninpigmented tissues of the eyes of some fresh water fishes
(trout, perch).

The pigment-protein couplex constituted

41.6% of the dry weight of the perch choroid, accounting
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for 74% of the zinc content of this tissue (6).
As stated above, species and individual differences
exist, but the various eye tissues can be placed in the same
order in respect to zinc concentrations in each of the species
examined.

This order, in descending concentrations of zinc.

is as follows:

Iris, choroid (plus pigment epithelium),

retina (minus pigment epithelium), lens, aqueous and vitreous humor, sclera, cornea, and optic nerve (6)".
The eyes of colored and albino rabbits were studied.
Zinc levels of 127 and 466 P.P.M. were found in the iris and
choroid respectively of the colored animals. compared with
54 and 86 P.P.M. for these tissues in the albinos (7).
The intravenous injection of 100 mg/kg body wt. of
di thiopheny lcarbaz.one, ache la ting agent of z inc and

0

ther

metals, causes blindness in dogs within 24 hours due to inactivation of zinc by chelation (103).
It has been shown by Bliss that horse liver alcohol
dehydrozenase can catalyze the redox interconversion of Vitamin Ai alcohol and aldehyde,

In the retina, this reaction is

catalyzed by retenue reductase which indicates this may be
identical or similar to alcohol dehydrogenase (5).

4.

Epidermal Structures

Although zinc has been found in essentially all body
tissues, a preponderant 15 to 20% of the total body stores
is concentrated within the skin and its accessory structures(31).
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What useful function zinc plays in these tissues is yet unknown, but as will be pointed out later, a definite function
of zinc in the skin is indicated beyond that of being a
simple storage reservoir.
In beriberi, a thiamine deficiency, a marked decrease
of zinc concentrations was observed in blood, hair, skin, and
nails (87).

Eggleton also produced evidence of an interest-

ing correspondance between beriberi and the zinc concentration
of human epidermal structures.

Subnormal levels of zinc were

found in hair, nails, and skin of beriberi patients.

Essen-

tially, the values for zinc are one half of the levels found
in corresponding epidermal structures (16).
Various authors working with zinc deficient dietary
regimens have described skin hair, hoof' or mucosal disorders
in a variety of animals.

Barney described a parakeratosis

of tongue mucosa to be a unique pathologic lesion in zinc
deficient monkeys (2).

Mills in Britain has described, among

other manifestations of zinc deficiency response, alopecia,
hyperkeratosis of skin in areas of hair loss, a coarsening
of wool or hair growth and alterations in the structural
growth of hooves in both lambs and calves (59).
Day. also Prasad, working with rats, has described
similar hair coat and skin changes in that animal after being
placed on a zinc deficient diet (12, 78).

A similar type of

skin lesion termed "parakeratosis" has been studied, described
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and treated in pigs in the U.S. since the 1940's (43. 95).
Reinhold and his fellow workers studying nutrition
in rural Iranian villages in the vicinity o.f Shiraz, a region in which the occurrence of zinc deficiency has been
previously observed in humans, found zinc concentrations of
hair to be significantly lower in village residents than in
similar control population in Shiraz.

Village diets con-

sisted predominately of flat bread prepared from locally
grown cereal grains, other. locally grown .vegetables and
relatively little animal protein.

City diets were

deversi~

fied and abundant in fruits, vegetables, and meats brought
from widely spread localities (81).
Although zinc concentrations in hair was significantly lower than those in controls, values for copper and
nitrogen concentrations did not differ between the two groups.
This fact that there was no difference in copper and nitrogen values indicates that the dietary insufficiency probably
is not due to decreased protein intake (81).
Lowest zinc concentrations occurred in the village
women.

Results of these studies provide evidence that con-

centrations of zinc in human tissues may be depleted, presumably as a result of limited intake (or decreased absorption) and possibly increased losses of zinc (as in childbearing and lactating women) (81).
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5.

Male Genital Tissues

Zinc concentrations of 1-2 mg per gram of dried human
semen have been reported (54).

Differences between sperm

and semen plasma were considered insignificant, though a
variable but significant percentage of seminal plasma zinc
was found to be dialyzable.
Zinc concentration in the human testes have been variably reported, but are, in general, higher than zinc levels
in other body tissues, except eye tissues.
Saito et al recently studied the zinc content of sperm
taken from various levels of the dog reproductive tract, similar to the previous study done in rats by Birnbaum (83, 4).
"Preprostatic" zinc levels were determined on sperm taken
from dog testes, epididymis and vas.

.Canine ejaculate sperm

zinc and canine seminal zinc determinations were also made.
The latter value was 1.75 mgZn/g dry wt.

The results (see

table 1.) indicate essentially no zinc uptake by sperm in the
dog until after the sperm have passed through the prostate
and have been bathed by the prostatic secretions.

This would

seem to indicate that a function of the dog prostate is to
contribute zinc to the spermatozoa,

In the rat, the zinc con-

tent (0.86 mg Zn/g dry wt.) of spermatozoa from the epididymis
is similar to the level reported (by Birnbaum) in ejaculated
spermatozoa {O.89 mg Z.n/g dry wt.} the determinations being
made by similar and comparable methods.

However, Birnbaum,

in his study, found that zinc uptake by rat spermatozoa began

\

J

f

TABLE 1.
COMPARISON ZINC LEVELS IN SPERM OF TWO SPECIES
TAKEN FROM VARIOUS LEVELS OF THE
REPRODUCTIVE TRACT
Ejacula tions

Testes

Epididymis

(dog)

O.l5

0.16

0.18

1.04

Birnbaum
(rat)

0.39

1.18

1.29

0.89

Investiga tor
Saito

NOTE:

Vas

All values are milligrams zinc per gram dry weight.

10.
at a much earlier location in the rat reproductive tract,
possibly beginning within the testes itself.

It is obvious

that preprostatic canine spermatozoa contain much less zinc
than the corresponding preprostatic rat spermatozoa.

In the

rat, epididymal and vasal spermatozoa are rich in zinc and
the prostatic fluid constitutes only a small part of the
ejaculate.

In the dog, on the other hand, preprostatic

spermatozoa are extremely poor in zinc and the bulk of the
ejaculate consists of prostatic fluid rich in zinc.

These

facts present evidence consistent with the hypothesis that
there is a biological need for zinc in the spermatozoa and
that, in the dog. it is a. function of the prostate to supply
this need.

In the rat, apparently. the spermatozoa do not

have to depend on the .prostate to supply their zinc requirements.

Although high levels of zinc are present, Gunn et al

have demonstrated that the prostate is .not necessary for
fertility and fecundity in the rat species (51, 26).

Since,

in the dog, it has been presumably shown that the greater
part of the zinc which is acquired by the spermatozoa is
contributed by the prostate, it should now be shown whether
this prostatic function is or is not essential to fertility
or fecundity in this

species~

Similar studies, such as the

above, have not been done in the human species to

date~

Values for prostate gland concentrations of zinc in
general tend to run very high.

Depending upon the investi-

gator, values range from 102 mg Zn/g dry wt. to 859 mg Z,n/g
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dry wt. (17,

53).

The activity of seminal carbonic anhydrase simultaneously increases with the zinc content, however, the amount
of enzyme calculated to be present only accounts for 3.5
percent of the total zinc present (52).

Thus, though car-

bonic anhydrase is present in human semen, its activity is
insignificant and can not account for the high zinc content
in semen (102. mg Zn .per g dry wt. human sem.en (103).

Neither acid or alkaline phosphatase activities appear to
be related to zinc content (21, 33).

6.
Whole Blood.

Blood

Various investigators report zinc values

in whole blood to range from 300 ug to 1500 ug Zn/lOO cc

(66, 98, 105).

Plasma values range between 80 ug and 390

ug/lOO cc while red blood cell concentration are reported
to be between 690 ug and 1440 ug/lOO cc.
to

~alc\1la te

Should one desire

percentages; 75 to 85 % of the whole blood zinc

is contained in erythrocytes, 12 to 22% is contained in serum
and 3% is contained in the leukocytes (96, 103).

However,

the individual leukocyte contains 25 times as much zinc as
does the individual erythrocyte (98).
Erythrocytes and Carbonic Anhydrase.

Under normal

conditions, the entire zinc content in erythrocytes can be
accounted for as carbonic anhydrase (36).

In 1940, Keilin

and Mann reported that the newly isolated, purified
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erythrocyte carbonic anhydrase molecule contained 0.33% zinc

(42).

Carbonic anhydrase is a zinc metalloenzyme that re-

versibly catalizes the hydration of carbon dioxide to bicarbonate and hydrogen ions according to the following equations
(14) :

carbonic

C02 + H2 0 rnhydras~ H~

~~COJ~

The enzyme is found in red blood cells, kidney, gastric mucosa and to a lesser extent, the central nervous
system, lungs, pancreas and salivary glands (11).
In most normal persons and patients with anemias;
(except pernicious anemia) polycythemia vera, secondary
polycythemia, leUkemia and congestive heart failure, both
erythrocyte zinc levels and carbonic anhydrase activity are
lowered in parallel fashion, so that the decreases are proportional to the decreases in hematocrit, hemoglobin levels,
and erythrocyte counts.

In

p~cious

anemias, the erythro-

cyte zinc concentration and carbonic anhydrase activity
remain nearly normal, although hematocrit, erythrocyte
count and hemoglobin levels are markedly decreased.

Thus

zinc and enzyme values per unit of R.B.C •• remain in the
normal range in the diseases listed above, whereas, in pernicious anemia, the zinc and enzyme values per unit of R.B.C.
are significantly elevated above normal.

A similar type re-

lationship exists in sickle cell anemia (99).
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Leukocytes.

Zinc has been thought to be associated

with the granules of polymorphonuclear and eosinophil cells,
the eosinophils containing 10times more zinc .than do other
leukocytes (55).

Indeed, a protein containing 0.3% zinc per

gram dry weight has been isolated from human leukocytes.
This zinc protein is responsible for 80% of all the zinc
found in human leukocytes and is differentiated clearly from
carbonic anhydrase.

While the protein is presumably an en-

zyme, the nature of its enzymatic activity is not known (34).
Fihl and co-workers proved zinc to be the principal
metal in the granules of eosinophilic granulocytes, and also
in the eosinophilic granules of peritoneal mast cells (69.

68).

They postulated that the metal. may be related to zinc-

dependent enzymes like dehydrogenases, amino-peptidase, and
phosphotases which occur in eosinophil granules and also in
neutrophils and mononuclear leukocytes.

An alternative ex-

planation suggested by Mashe would be that zinc here, as in
the islets of Langerhans, may have a stabilizing effect on
some specific protein (50).
Serum 2!: Plasma.
yet been well studied.

The role of zinc in plasma has not
It would seem quite probable that

zinc becomes bound into zinc-protein complexe.s and metalloenzymes.

What is not excreted or removed from circulation

by passage into intracellular compartments. becomes a large
pool of readily exchangeable zinc.
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"Firmly" and "loosely" bound moieties are present in
all serum protein fractions, ,though zinc seems most strongly
bound to the globulins (112).

Others have felt that a ma-

jority of the zinc is loosely bound to albumin and carried
in this fashion (103).
Himmelhoch recently discovered three, hithertofore,
new unknown serum zinc proteins.

These seem to be "firmly"

bound zinc-protein complexes that do not overlap the chromatographic acti vi.ty profiles of .some other zinc-protein complexes found in serum; lactic and dehydrogenase, alkaline
phosphatase, carboxypeptidase and glutamic dehydrogenase.
These proteins have not yet been c.hara.cterized (32).
Eminians and others, have suggested normal zinc levels
in serum or plasma to be in the range of 90 to 120 pg/100 cc
(17, 103).

As will be brought out later in this discussion,

a great variety of diseases tend to affect the serum zinc.
either increasing or decreasing the levels from the normal.
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Milk

In cows, the concentration of zinc in milk (3-5 mg/L)
is about 10 times greater than that of iron, 100 times greater
than that of copper, iodine and manganese, and 1000 times
greater than that of cobalt.
found in human milk (96).

Similar dif,ferences may be

Colostrum, in all species studied,

contains 3 to 5 times the amount of zinc that is found in
later true milk.

Values as high as 20 mg Zn/L have been
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observed in humans at the time of delivery.

The zinc level

then returns slowly to the normal value (3-5 mg/L) over a

6 month period (3).
Nishimura easily demonstrated zinc deficiency in
baby mice, simply by exclusion of. zinc-rich colostrum from
their diets by fostering them at birth with mothers at later
stages of lactation.

Newborn mice nursed by their own

mothers for 2*-4 days before transfer to foster mothers,
grew normally, whereas newborn mice that were fed, for
periods of 3-5 days by foster mothers that had been lactating 13 -18 days, and were .then re turne d to the ir own mo thers •
usually develope.d disorders somewhat typical of zinc deficiency which could be prevented by, .or which responded to,
oral administrations of zinc (63).

This phenomenon has not

yet been studied in humans.
8.

Urine

In consideration of the urine zinc levels and the
normal kidney blood perfusion, one could postulate a rather
efficient system of tubular reabsorption of zinc.

Normal

individuals excrete in the urine, relatively small amounts
of zinc daily (0.1-0.9 mg/day) (96).

Significant zincuria

may occur in; Albuminuria, average 2.l mg Zn/24 hr (20), postalcoholic cirrhosis, average 1.0 mg Zn/24 hr (101), postoperative period, range 2.8 mg Zn/24 hr initially to 1.3 mg
Zn/24 hr on day 20 (31).
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9.

Bone

Early researchers felt that zinc resembles lead and
nickel in its tendency to accumulate in the bones, and they
reported relatively high values of zinc for bones and teeth
(150.250 ppm) (9, 15, 49).
Day and McCollum in 1940, while studying zinc deficiency in the rat, found a reduction in the proliferative
activity of cartilage cells and a decrease in .osteoblastic
activity, as manifested by a decrease in metaphyseal bone
benea th the cartilage plate (12) ~

Prasad, in his initial

study of apparent zinc deficiency. in human males, found
dwarfism to be a .part of the clinical picture (72).

Zinc

is in some way bound to the initiation of. mineralization of
preosseous tissue and is progressively incorporated within
the preosseous tissue as mineralization occurs and it is
still present in fully calcified .tissue.

On the basis of

zinc-65 and biochemical studies, it can be saia that zinc is
literally sequestered in calcified bone and masked for histochemistry and is not available for ionic exchange.

It has

been postulated that zinc helps to catalyze the calcification
process and therefore, is essential to the growth or metabolism of bone though the mechanism has not been established
(30) '.

10.

Liver and Pancreas

Zinc, unlike iron and copper, is not normally stored
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in large amounts in the liver, in fact, studies with zinc65 indicate a rapid deposition and high turnover rate in
liver, pancreas, kidney, pituitary and adrenals.

However,

eax-lier studies have indicated that both liver and pancreas
contain approximately twice the amount of zinc contained in
other body. tissues (67).

This seems to. be controversial.

Excretion of absorbed zinc. from the body largely in
the feces. is thought to be mainly by way of the pancreatic
secretions which contain a quite high concentration of zinc,
probably due to the pancreatic zinc metalloenzyme, carboxypeptidase (103. 58).

It has been shown by radioactive zinc

studies, that the zinc-65 content of bile is very low (58).
Much early research has been carried on with the pancreas and zinc metabolism due to the once thought possibility
of a zinc - insulin interrelationship holding the key to
diabetes alleviation (103).

However. this ha.s largely been

disproven now.
11.

Sweat

Prasad and his co-workers, in a study from Egypt,
found the zinc content of Whole sweat to be 115
and that of cell-free sweat to be 93

± 26

±

30 mg%

mg%. Thus, in a

hot climate where sweating can be excessive, one may lose up
to 2 to .3 mg of zinc per day (75).

This is thought to be

one of the mechanisms causing zinc deficiency in humans.
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CHAPTER III
ZINC DEFICIENCY IN HUMANS
1.

Etiology and Manifestations of Zinc Deficiency
Up until 1961, when Prasad and eo-workers reported

on their work in Shiraz, Iran, the possibility of zinc deficiency states in humans had not been. widely considered.

As

previously stated, Eggleton produced evidence of subnormal
zinc levels in epidermal .structures in beriberi sufferers,
however,.this was not considered to be zinc deficiency per
se (16).

Zinc deficiency. as found in Iran and later seen

similarly in Egypt, was manifested. by what appeared to be a
severe iron deficiency anemia in conjunction with arrested
growth, hepatosplenomegaly and hypogonadism in young male
adults (73, 74).
The conclusion that .these patients were manifesting
zinc deficiency is based upon the following.:

(a) the zinc

concentrations in plasma •. red blood 0_11s and hair were decreased as compared. to normal subjects: (b) the excretion
of zinc il'l urine and sweat was decreased; (c) the radioactive
zinc-65 stUdies which reve.aled that the plasma zinc-turnover
rate was greater in the patients. the 24-hour exchangeable
pool was smaller, and the excretion of zinc-65 in stool and
urine was less in the dwarfs than the control subjects (74).
The possible factors responsible for zinc deficiency
in these subjects are several, (1) Poor availability of zinc
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from the diet normally consumed in the villages of Iran and
Egypt; either low content of zinc or zinc being complexed
by high levels of phytate in the bread .and beans of the
Phytate being a strong complexer o.f zinc.

diet~

(2) Blood loss

caused by hookWorm Dr schistosomiasis infestation.

()

zinc

lost by excessive sweating ('74) •
.The anemia in all cases was hypochromic, microcytic
in type and related to iron. deficiency .and was completely
corrected .by oral administration of. iron salts.

However,

the administration of iron salts did. not. correct the hepatosplenomegaly or alleviate the growth. retardation or hypogonadism~

This. would seem to indicate seve.re anemia and

iron deficiency are not necessary factors for growth retarda tion and hypog.onadtsm ('76) •..
No evidence for dei'i.c.iency of other essential trace
elements or vitamins were obtained ('76).
In all cases, following treatment with zinc, the size
of the liver and spleen decreased markedly.

The rate of

growth increased and was greater in patients who received
supplemental zinc as compared to those who received iron. instead or just plain hospital diets.

Pubic hair appeared in

all cases within '7-12 weeks after zinc supplementation was
started.

The genitalia size became normal and secondary

sexual characteristics developed within 12-24 weeks in all
cases which received zinc.

On the other hand, no such changes
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were observed in the iron supplemented group or on hospital
diet alone in the comparable length of time.

Two dwarfs

which refused to take part in the study were followed in
their villages for 1 year.

They failed to grow or show any

changes in their sexual development (76).
Liver function tests were all unremarkable, except
for the serum alkaline phosphota.se which increased to normal
levels following treatment (73).
2.

Absorption and Excretion

Like iron, zinc appears to be absorbed only to a
limited extent from the intestine •. Studies using zinc-65
have shown that only 5 to 10% of dietary zinc is absorbed
at a normal intake level (67).

Since the average well

balanced human diet supplies 10 to 15 mg. of zinc per day,
the daily intestinal.absorption has been estimated to be
0.5 to 1.5 mg zinc per 24 hour period (19).

The site of

absorption of zinc from the intestine and the mechanisms
involved are not understood at the. present time (67).

No

specific plasma protein has been definitely identified as
a transport protein for zinc, as is true in the case of
iron (transferrin). and. of copper (ceruloplasmin), but
some think that zinc may combine with thep globulin, transferrin, noncompetitively with iron and thus this protein
be responsible for the transport of both iron and zinc in
the body (106).
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O'Dell and Savage have shown that phytic acid, found
at high levels in some grains and vegetables, decreases the
absorption of zinc similar to its effect on the absorption
of iron (65, 64).

Also, high levels of calcium and phos-

phate have been reported to inhibit intestinal absorption
of

zinc~

Geophagia or clay eating, (clay containing increased

levels of phosphate) has been suggested as one of the contributory factors in .the patients described from Shiraz in

1961 (73).

The pH of the diet, or of the intestinal tract,

or both, may also influence the availability of zinc (60).
Most of the zinc intake is excreted unabsorbed in the
stool, chiefly, as stated above, in the pancreatic secretions
and a small amount in the bile (61).

.compared with the

amounts ingested, the amount of zinc excreted in the urine
of normal individuals are exceedingly small, on the order of

0.1-0.9 mg. per day.

Zinc excretion appears to be independent

of the urinary vo lume (34 L

However. as will be taken up

later, urinary zinc le.vels may be quite elevated in certain
disease states.

3.

Endocrine Manifestations

Sandstead and his co-workers (84, 85), working with
Egyptian dwarfs, apparently zinc deficient, similar to those
reported upon by Prasad (74, 75), masterfully studied with
rather involved research, the endocrine manifestations of
those dwarfs.
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Noting that zinc apparently concentrates to some extent in the pituitary (45). and that pituitary gonadotropin (57) and corticotropin (35) are apparently augmented by
zinc in eXperimental animals, and observing some of the
cardinal manifestations of panhypopituitarism in the dwarfs,
(arrested growth and osseous development though normally
proportioned bodies, hypogonadism,-depressed ACTH production,
and increased sensitivity to insulin). they studied various
pa~meters

of endocrine function. in these dwarfs (29)8

Linear growth, bone age, thyroid function, glucose
tolerance, pituitary corticotropin.reserve, adrenal cortical function and pituitary gonadotropin excretion were evaluated by standard techniques.
Each child, after preliminary evaluation, was treated
either by diet alone or with supplementation of either iron
(1 gm/day) or zinc (90 mg/day) and. followed for a long period of time.

Controls were included Which used their normal

diet, but with or without supplementation with iron or zinc.
Patients receiving iron gained in height, but the increase was not as striking as the growth acceleration in
those receiving zinc.

Two patients originally given iron

were subsequently given zinc and an additional growth increase occurred.

The plasma zinc concentration of these

patients receiving iron approached normal, (the zinc source
presumably the diet), though in some cases the serum iron
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concentration remained low.

The zinc supplemented group had

a growth acceleration despite the continued presence of low
hemoglobin and serum iron concentrations.

Neither of the

two village controls who received no micronutrient therapy.
grew during the observation period (greater than 300 days).
Overt hypothroidism was not present and the pituitary-thyroid interactions were generally normal.

The major-

ity had normal PBI's and normal to elevated 24 hr RAT uptakes.

Serum cholesterol was low.
Liver function tests were normal in nearly all

patients, and liver biopsies were done, though there was no
evidence grossly or microscopically of fat malabsorption.
The D-xylose absorption test was normal.
A variety of abnormal curve.s were obtained in the
oral glucose tolerance test with the majority of patients
having an apparent delayed absorption of glucose.

Rela-

tively prolonged elevations in blood sugar occurred in others.
Intravenous glucose tolerance tests were normal to
slightly accelerated in nearly all patients indicating adequate insulin production.

Three out of the four patients

tested, using the Engel-Scott insulin-glucose test (18),
showed striking intolerance to intravenous insulin (0.1 units
regular insulin/Kg bOdy weight) requiring termination of the
test but indicating hypopituitarism in these patients.
The responses to exogenous adrenocorticotropin (AOTH)
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and Metopyrone infusion test were frequently abnormal.

The

mean basal 17-hydroxysteroid (17-0HS) excretion was 6.24 ±
2.6 mg/24 hre

After ACTH stimulation, (40 units IV in D5W,

given over 8 hours, beginning between 8 and 10 A.M. on 3
consecutive days), the rise in urinary 17-0HS was frequently
delayed, or following an initial rise, there was a fallon
successive days.

These findings suggested a decreased adrenal

reserve, possibly secondary to decreased ACTH production or
release.
The excretion of l7-0HS following the Metopyrone infusion test was subnormal in the majority of patients, both
in terms of absolute rise in 17-0HS excretion and in comparison to the ACTH response.
The responses to intravenous Metopyrone coupled with
the ACTH tests suggest the presence of limited pituitary
ACTH reserve.
After periods of treatment with zinc. iron, or diet,
the pituitary-adrenal axis was re-evaluated, in six patients,
and showed an improved response to ACTH in four patients, but
the response to Metoyrone infusion improved in only one.

Al-

though the member of observations were too small to obtain
valid conclusions as to the cause of. improvement, their data
suggested that increased response from A.CTH and Metopyrone
was associated with improved zinc nutrition and was not dependent upon iron.
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Hypogonadism in the group of patients was manifested
by absence of pubic, axillary or facial hairs, a small penis
and atrophic testes (prepuberant sexual development).

Uri-

nary pituitary gonadotx'opins al'ld_ l?-Ketosteriods were low
in all patients with the average l?-Ketosteriod excretion
for the group approximating the normal level for eleven year
old children.
Diet and iron therapy were followed by slow maturational changes •. In contrast, treatment with zinc was followed by. surpr.isingly accelerated sexual maturation.

---

In

some, pigmented.pubic,extremity, and facial hair appeared
within J weeks of beginning of zinc treatment and maturational changes in the penis and. scrotum could be seen.
Early growth of pubic and lip. hair was followed by an increase in genital size. the grow.th. of additional facial,
extremity, pubic, and finally. axillary hair.

Urinary ex-

cretion of pituitary gonadotropin also became normal in
some patients.

The two untreated control patients remaining

in the village, did not show change in genital site or development of secondary sexual characteristics during the
observation period of greater than 1 year.
The endocrine abnormalities in this group of patients
are compatible with hypopituitarism.

In this group, growth

failure and hypogonadism are the most outs.tanding features,
but also, decreased pituitary ACTH reserve and an abnormal
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oral glucose tolerance have been found.

Here, hypothroidism

did not appear to be. an obvious problem, however, the thyroid
studies did suggest iodine deficiency in .some cases.
Zinc therapy caused an improvement in these clinical
fea tures and apparently induced puberty.

.Di.et and iron

therapy alone, while tending to alleviate somewhat, did not
bring about a marked improvement in the symptoms.
It. is .probably still a little.soon to denote a cause
and effect relationship between zinc de.£iciency and hypopituitarism, since all.the evidence is not yet in, but indications and evidence is certainly in that direction.
CHAPTER IV

BIOCHEMICAL ASPECTS OF ZINC METABOLISM
1.

Zinc Metalloenzymes

Continued research in the past few years seems to
make it clearer that most micronutrients function through
their relationship with enzymes, hormones, nucleic acids,
and other proteins.

Although zinc has been studied in liv-

ing organisms for many years, it has only been recently
that one can presume the manner of zinc participates in
metabolism.

Its relationship with enzymes has been a center

of recent biochemical research in the. field.
Although Keilin and Mann report,ed the isolation of
carbonic anhydrase in 1939, it has only been recently that
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the impetus of study has mushroomed into the discovery of
some twenty zinc-containing metalloenzymes from a great
variety of species.

This would seem to indicate an overall

importance of this element in metabolism (93).

See Table (2).

"The zinc atoms in these molecules are specifically
and firmly incorporated into the protein such that they can
be thought of as a single physical entity in their native
state.

Thus, during isolation of the enzyme, the ratio of

zinc to protein rises to a fixed. limit, as does the ratio
of activity to protein.

As.a result, the ratio of zinc to

activity also reaches a fixed limit, while the ratio of the
sum of all other metals to activity simultaneously approaches
zero.

With complete purification, the number of gram atoms

of zinc per mole of apoenzyme is an integral value, attesting
to the specificity of the association and implying stoichiometry.

The concomitant rise of zinc with activity suggests

that the. metal is specifically and critically related to
enzymatic function.

In this regard, these characteristics

of zinc metalloenzymes contrast with those of zinc-metal-protein complexes, a large group of enzymes which may require
zinc as one of several metals for activity, but which cannot
be isolated with a metal in situ, due to the weaker and less
specific association between it and the protein (104)".
Carbonic Anhydrase.

First repor.te.d as a CO2-protein

catalyst in 1932, this enzyme has been found in a number of

)

TABLE 2.
ZINC METALLOENZYMES
Enzyme
Alcohol dehydrogenase
Alcohol dehydrogenase
Alcohol dehydrogenase
Lactate dehydrogenase
Malate debydrogenase
D{-) Lactate-cytochrome C reductase
D-Glyceraldehyde-3-phosphate dehydrogenase
D-Glyceraldehyde-3-phosphate dehydrogenase
Glutamate dehydrogenase
Alkaline phosphatase
Alkaline phosphatase
Alkaline phosphotaae
Carboxyp.eptidase A
Carboxypeptidase B
Carboxypeptidase B
Neutral protease
Aldolase
Aldolase
Carbonic Anhydrase
Carbonic Anhydrase

Source
Yeast
Equine liver
Human liver
'Rabbit. muscle
Porcine heart
Yeast
Rabbit and bovine muscle
Yeast
Bovine liver
E. coli
Mammalian kidney
Human leukocytes
Bovine pancreas
Porcine pancreas
Bovine pancreas'
B. subtilis
Yeast
Aspergillus
Bovine erythrocytes
Human erthrocytes
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organisms including plants. cattle, sheep, and humans.

In

erythrocytes, it acts as a catalyst to mediate CO 2 excretion from the body. It is thought to have a molecular
weight of 30,000 and contains a zinc concentration ranging
from 0.2% to 0.3% depending upon its source.

The chemical

details of the bonding between. zinc and the protein are not
known, neither also is. the mechanism of its action known (103).
Alkaline Phosphotase.

This e.nzyme has been isolated

from kidney, E. coli; and human leuk.ocytes.

It is thought

to contain 0.15% of firmly bond zinc with several metal
binding sites per each molecule enzyme (103).

Prasad found

depressed levels of alkaline phospha.tase .which reverted to
normal by zinc supplementation (73).
Lactic Dehydrogenase.

Apparently an NAD-dependent

enzyme. first isolated from rabbit skeletal muscle, this enzyme has not been completely characterized but seems to
catalyze the redox interconversion of lactic and pyruvic
acids (103).
Glutamate Dehydrogenase.

Also a NAD-dependent enzyme,

this enzyme is different from other dehydrozenases by not
acting on primary or secondary alcoholic groups, but which
catalyzes the reversible oxidative deamination of an amino
acid.

It is thought to have a molecular weight of 1,000,000;

a much larger molecule than other pyridine nucleotide-dependent enzymes (103).
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Carboxypeptidase.

First purified from pancreatic

juice, this enzyme has a molecular weight of 34,000.
molecule contains one atom of zinc.

Each

When zinc is removed

from the enzyme, activity is lost in direct proportion.
Readdition of zinc ions fully restored activity (102, 103).
Its main function is to catalyze the hydrolysis of
carboxy terminal peptide bonds in proteins and peptides.
but it also hydrolyzes esters.

While enzymatic activity may

be resotred to the apoenzyme in varying degrees by the addition of other metals, these metals do not give the complete
spectrum of specificity of action that is attained by the
native zinc enzyme (93).
Hsu, studying zinc deficiency in rats, reported that
it caused decreased activity of pancreatic carboxypeptidase
B or liver alcohol dehydrogenase.

The observed reduction of

enzymic activity may be related to poor proteolysis in the
intestinal tract and therefore, poor utilization of feed
which occurs in zinc deficient rats (37).
Alcohol pehydrogenase.

Isolated from yeast as early

as 1937. this enzyme has also been found in liver of various
species, and is thought to present zinc atoms as an active
enzymatic site with an unexplained interaction between NAD
and alcohol dehydrogenase.

Thus, this enzyme also is appar-

ently a NAD-dependent enzyme whose concentration and, or,
activity varies directly with the activity of NAD (10,3).
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One function that has been studied is the conversion
of vitamin A alcohol to vitamin A aldehyde in the process
of vision.

The essentiallity of zinc to this enzyme can be

seen, as mentioned earlier, by causing blindness in dogs due
to binding of zinc by chelating agents.
Evidence seems to indicate formation of enzyme-coenzyme-substrate complex with the zinc atom functioning at or
in close proximity to the active site on the enzyme molecule

(93) •
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Zinc-Enzyme Complexes

In addition to being a necessary constituent of a
number of metalloenzymes, zinc functions as a co-factor,
apparently increaSing in some nonspecific manner the activity of a number of other enzymes.

These include arginase,

carnosinase i> .leci thinase, eno.lase, aldolase, ozaloacetic
decarboxylase, alkaline phosphatase, histidine deaminase and
a number of. mono-, di-, and tri-peptidases (103, 93).
CHAPTER V
ZINC RESEARCH IN DISEASE PROCESSES
Current literature is beginning to show important and
significant reports of promising research on zinc as it is
related to disease processes and basic cellular metabolism.
These will be briefly summarized.
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1.

Post-Alcoholic Cirrhosis and Hepatitis

It has been previously stated that zinc is an essential component oi' several hepatic enzymes, including glutamic
and alcohol dehydrogenases.

Several investigators (103, 106,

23) have reported a decrease in serum zinc levels in patients
with post-alcoholic cirrhosis.

Vallee (lOJ) reported abnor-

mally high urinary zinc excretion in these patients, in the
order 1000

± 200 ug per 24/hrs. The. abnormal variance of zinc

levels in these patients tends to. correlate positively with
the severity of the disease.

Liv.er tissue zinc concentrations

were decreased below normal levels.
Since zinc is an essential component of the enzyme,
liver alcohol dehydrogenase, and therefore, participates in
the oxidation of alcohol, and since ethanol is considered to
have an etiologic role in thedevelo.pment of Laennec's cirrhosis, it. follows that low zinc levels in the body may play
some role in the development of alcoholic cirrhosis.

This

has been substantiated by Vallee (103) to the extent that
the oral administration of zinc quickly resolves these abnormalities of zinc metabolism thus suggesting a "conditioned" zinc deficiency, and producing a tendency toward
restoration of normal liver function.

Whether or not this

also produces a reversal or termination of the cirrhotic
process'_has not as yet been determined or substantiated.
It has been suggested by studies that following alcohol
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ingestion, the serum zinc concentration decreases (91).
Similar results have been reproduced by Kahn and co-workers,
in carbon tetrachloride induced liver cirrhosis of rats

(40)~

It has been proposed that high blood levels of alcohol could deminish the. activity of zinc containing alcohol
dehydrogenase and result in its degradation with increased
zinc excretion (100).
The tendency to low serum zinc concentrations in cirrhosis could be regarded as a manifestation of zinc deficiency or it could be the result of low levels of zinccarrying protein.
Bilirubin.inhibits trypsin. chrymotrypsin, pancreatic
amylase and intestinal alkaline phosphatase (1, 90).

Fletman

suggests bilirubin may do other than chelate zinc and may
bind protein or inhibit enzyme systems not containing zinc.
In vitro reversal of bilirubin inhibition can be achieved by
addition of zinc sulfate.

There may be related cause and

effect in advanced Laennec's cirrhosis with low serum zinc
levels and increased urinary excretion of zinc and decreased
levels of hepatic alcohol dehydrogenas.e as have been reported
above in Iaennec's cirrhosis.

Since hyperbilirubinemia is

oftenpreseI1:t in last stages of post-alcoholic cirrhosis,
bilirubin may promote excretion of zinc as a bilirubin-zinc
chelate.

This

~yperbilirubinermia

lated with zincuria (22).

has not yet been corre-
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Kahn and co-workers found a tendency to an elevated
serum zinc in acute hepatitis, which they felt could be a
result either of release of zinc containing enzyme from
damaged hepatic cells or of an increase in .zinc binding
protein owning to its release from the liver, analogous to
the elevation of serum iron found in aoute hepatitis.

Th.ey

also noticed an abnormally high urinary zinc in half of
their patients (39)"
2.

Respiratory Distress Syndrome

An interesting side aspect to zinc-enzyme complex

interaction may be found in respiratory distress syndrome
of premature infants and zinc-carbonic anhydrase activity.
In a study made by Kleinman, .normal, full term, newborn infants had approximately 25% of the carbonic anhydrase activity of adults.

Premature infants without respiratory dis-

tress syndrome, average 13% of adult enzymatic activity and
those infants with respiratory distress syndrome average 5%
of adult activity (44).
The enzymatic activity from premature infants with
the syndrome were significantly. lower (P le.ss than 0.001)
than the activities from premature infants without the syndrome.

See Table (3).
Newborn babies have blood zinc levels much lower than

normal adults, but there is no significant difference in
blood zinc between prematures with and prematures without

TABLE ).
COMPARISON OF CARBONIC ANHYDRASE AND ZINC LEVELS
IN ADULTS, FULL- TERM NEWBORN INFANTS. AND

PREMATURE INFANTS WITH AND WITHOUT
RESPIRATORY DISTRESS SYNDROME

Subjects

Number

Carbonic Anhydrase
E.U./ml

Zinc
pg/ml

Ratio of Carbonic
Anhydrase to Zinc
Concentration
E.U./)1g

Adults

15

4429 ± 100

5.45 + 0.18

820.0 + 19.5

Full Term Newborn Infants
(40 or more wk gestation)

76

1100 ± 56.0

1.71

± 0.06

602.5 ± 28.4

respiratory distress syndrome

26

584 ± 62.0

1.47

± 0.07

449.5 ± )8.4

Prema ture infan.ts
(40 wk gestation
with respiratory distress
syndrome

19

2)4 ± 22.6

1.59 + 0.12

-

166.1 ± 24.1

Premature infants

(4.0 wk gestation) without
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respiratory distress syndrome.

Thus, the enzymatic activity

per microgram zinc was considerably and significantly lower
(P<O.OOl) in the premature infants who had the syndrome.
Kleinman. postulates perhaps one of the carbonic anhydrase isoenzymes found at low levels in adult blood are
at high levels in fetal blood •. Tappan. et al. have shown that
newborn red blood cells have lower carbonic anhydrase specific activities than adult red cells (92.).

Kleinman further

suggests that a change of low specific activity to high
spcific activity carboni.c anhydrase occurs with maturation
and that this change is slowed or altered in infants with
the respiratory distress syndrome.

3.

Skin Diseases

Significantly lowered plasma-zinc concentrations were
found in patients with psoriasis, othe.r dermatoses and venous
leg ulcerations.

See Table (4).

.This finding of abnormally

low zinc concentrations in the plasma of patients with widely
differing dermatoses suggests that similar non-specific
mechanisms may be responsible (24).
A study done by Kozlowski and associates, unfortunately without statistical controls, found a decrease in the
zinc content in granUlocytes in patients with advanced skin
neoplasia, patients with non-specific skin diseases but with
coexistent internal malignancy. patients with disorders of
the lympho-reticular system and in patients with psoriasis

J

TABLE 4.
ZINC CONCENTRATIONS IN PATIENTS WITH SKIN DISEASES
AND IN HEALTHY CON'l'ROIS

Subjects

Number

Age (yr)
(Mean & Range)

Mean Plasma Zinc

Controls

41

30.6(19064)

18.1

1.92

Psoriasis

20

48.3(19-64)

15.5

2.49(p<:0.OOl)

Ichthyosis

10

35.1{16-63)

16.5

2.4J(p<o.o,5)

9

58.4<.,1-61)

15.4

1.?1(p~O.OOl)

13

45.5(15-61)

15.4

2.J9{p<.O.OOl)

Chronic Venous
Leg Ulcers
Other Skin Diseases*

(UM)

Standard Deviation

*DIAGNOSIS, Lichen planus ()
eczema (3), urticaria (2). sclero4erma (1), pemphigoid (1), dermatitis herpetiformis (1), rosacea (1), chronic discoid lupus erythematosis (1).
P : Significance of difference between test and control means.
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and erythrodermia (46).
4.

Thermal Burns

A number of complex metabolic alterations occur as
the result of full thickness thermal burns.

Since approxi-

mately 15% to 20% of the body zinc store is normally found
within the skin, alterations in zinc metabolism might be expected to oc.cur in thermal burn patients ..
Henzel reports a marked body zinc deficit with an
initial sharp loss of zinc fo.llowing severe thermal burns
in over forty patients .which la.sts up to 2 to .3 months following the injury before reverting to normal (.31).
Although the skin is a large reservoir of zinc storage, an alternative reason for the zinc deficit and urinary
loss must be found beyond stating the thermal burn is the
etiology of the loss . since. zinc stores in a full thickness
burn should theoretically be lost to body use since the burn
site is no longer blood perfused tissue.

This has not yet

been explored.

5.

Wound Healing

Acceleration of normal healing by dietary zinc supplementation was accidentally discovered in rats in 1955 by
Strain (88).

It, however, was not until 1967 that successful

implementation of this finding was reported in humans (70).
Comparative studies of wound healing were made with
and without oral zinc sulfate therapy in young human male

39
subjects by measuring the rate of wound healing in wounds
formed by pilonidol-sinus tract excisions that were allowed
to heal by secondary intention.

The rate of healing was

determined by measurements of wound. volumes and the number
of days for complete repair.

Patients in. the treated group

were given 150 mg of elemental zinc daily in the form of
zinc sulfate in addition to normal diet.

Patients in con-

trol group were given no medication other. than normal diet.
As can be seen in Table (5), the healing rates (mI. per
day) were nearly three times greater in the treated group
as compared to the control subjec.tse

Al though the experi-

mental group had wound volumes much larger than those in
the control group, the larger wounds healed 43% sooner with
orally administered zinc sulfate (71).

Although the medi-

cated group healed more rapidly throughout the course of the
trial, differences were small. during the first fifteen days.
Of further significance was the difference in wound
appearance between the two groups.

Wounds in the patients

on zinc sulfate therapy had cleaner, pinker and healthier
granulations with considerably less purulent exudate than
wounds in the control group.
Healing of the granulating wounds could be correlated
with the concentration of zinc as measured by hair analYSis
(70) •

Savlov et al reported in 1962 that radioactive zinc

TABLE 5.
COMPARISON OF MEANS OF WOUND VOLUMES. DAYS FOR COMPLETE HEA.LING f
AND HEALING RATES IN UNTREATED CONTROL PATIENTS AND

PATIENTS TREATED WI'I'H ZINC SULFATE

Wound Volume
hill}

Mean of Control Patients

25.0

,32.3

80~1

± 13.7

0.44 ± 0.09

Mean of Treated Patients

24.6

.54.5

45.8 ± '4.6

1.25 ± 0.,30

Significance

Days for
Complete Healing

Healing Rate
(ml/day)

(yr)

Age

p<:0.02

p<O.Ol
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is prefereptially concentrated in healing tissues with the
peak of activity during the first days after injury. followed
by gradual decrease.

But migration of zinc into wound

appears to be temporary, since at the time of complete scarring, one hundred days after injury, zinc-65 was not detected in the scar. although the radioisotope was still
measurable in most tissues (86).
6.

Post-operative Zincuria

As evidence seems to be accumulating that zinc levels
may become depressed following significant stress or trauma
to the biologic organism, man included, surgeons could anticipate the zinc levels to be affected by operative trauma.
Indeed, this seems to be the case. ' Henzel reports significant increases in 24 hour urinary excretion of zinc {which
reflects acute changes in biologic zinc stores} following
operative procedures as compared to non-operated controls
(31).

Twenty-four hour urinary excretion of zinc averaged

0.70 mg/day in the control patients as compared to 1.28 mg/
day urinary excretion of zinc during the 20-day postoperative observation period.

During the first three postopera-

tive days, daily losses as high as 2.8 mg were recorded per
the 24-hour collection periods •.
While postoperative zincuria may not represent a problem in the normal healthy operative patient, it could
significantly tilt the balance of zinc stores and cause
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further depletion in those patients with borderline or subnormal stores and cause a tendency to delayed or resistant
wound healing.
Consideration should be given to possible zinc supplementation in those patients presenting delayed wound
healing.

7.

Malignant Diseases

The status and role zinc may play in neoplastic
disease either as an etiology. or a theraputic role· remains
at best sketchy and contradictory with probable multiple
factors contributing to the confusing state.
Vallee (103) reports a number of authors who have
studied zinc in relation to neoplasm.

They need not be re-

peated here.
Erythrocyte zinc levels in myeloproliferative disorders were studied by Valberg who also reports a number of
other contradictory authors on zinc status in hemoplastic
diseases (97).

Valberg found erythrocyte zinc to be in-

creased above normal in all diseases stUdied, but significant to P<0.05 only in. acute leukemia, chronic lymphatic
leukemia, chronic myelogenous leukemia, Hodgkin's disease.
and metastalic carcinoma.

The greatest increase in mean

zinc levels was present in chronic myelogenous leukemia
and Hodgkin's disease, the smallest increase in chronic lymphatic leukemic and values intermediate between these results

were found in acute leukemia, multiple myeloma and in carcinoma..

The values in this study are in ac.cord with certain

previous observations.
Reduced levels of zinc in granulocytes, in contrast
to above reported increased erythrocyte zinc levels, are reported by Lawkowicz in patients with wide range of neoplastic
diseases (47).

However, values of granulocyte zinc are re-

ported above normal in chronic lymphatic leukemia.
Alterations of zinc levels in tissues which presumably
are not directly participating in the neoplastic process,
suggests a generalized disorder of zinc metabolism.
Changes in the activity of certain enzymes have been
reported in normal and tumor tissues of tumor-bearing animals
and man (25, 10).

Rosoff suggests that since the activity

of some enzymes depends upon the presence of specific trace
metals,

ce1.~1l:lar

derangements resulting in neoplasia may be

linked with changes in trace metal concentration (82).
Conjecture concerning the role of zinc in neoplastic
disease may be premature at this time.
8.

Benign Prostatic Hypertrophy and
Prostatic Carcinoma

The in vivo concentration of zinc in human prostatic
tissue is low in cancer and very high in hyperplasia as compared to normal prostatic tissue (27).
inverse in the in vitro situation.

This relationship is

Probably this is an
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expression of the in vivo saturation of zinc. binding sites
in the hyperplastic tissue and the relatively unsaturated
sites in carcinomatous prostatic tissue (28).

Gyorkey hypo-

thesizes a zinc-chelation phe.nomenon in BPH and a depression
of leucine amino peptidase levels, a zinc metallo enzyme in
prostatic carcinoma (27).

9.

Myocardial Metabolism and
Cardiovascular Disease

It has been known for several years that a significant decrease in serum zinc is observed in myocardial infarction with levels averaging 67 ± 13.8 pg zinc per 100 cc as
compared to 120 ±
patients (109).

19~0

pg zinc per 100 cc in normal control

This is accompanied by changes in a variety

of enzymes activities and an increase in copper concentration
(108).
Following the ingestion of oral alcohol. it has been
found that zinc is liberated from the myocardium.

In peri-

pheral venous studies of alcoholic patients, as zinc level.s
fell, alcohol dehydrogenase activity rose, suggesting a

re~

lationship between the changes in zinc and alcohol dehydrogenase (110).

Similar observations have been made in myo-

cardial infarction, where a decrease in plasma zinc concentration is accompanied by an increased activity of malic
dehydrogenase and lactic dehydrogenase (109).

The explana-

tion for the decrease in serum zinc levels and concomittant
rise in enzyme activity remains unclear, but it does not
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necessarily indicate an increase in enzyme concentration but
may be an increase in enzyme activity.
Hair zinc levels .were observed to be decreased below
normal patients in patients with proven atherosclerosis.
The median zinc

lev~l

of hair was. 62 ppm, which contrasted

sharply with the provisional normal of 125-150 ppm (89).
This is consistent with a previous report by Volkov, who
found a significant decrease in the zinc content of plasma,
aorta, liver, myocardium and pancreas in a large group of
patients with atherosclerosis (107).
10.

Zinc Toxicity

Excess zinc ingestion produces an acute and transitory illness within a few minutes after ingestion with the
symptoms including malaise, dizziness, tightness of the
throat, emesis, colic and diarrhea.

Usually, this can be

attributed to the preparation of acid. f'oods (fruits, juices,
stewed fruits, in galvanized containers, resulting in solubilization of zinc.

Treatment is symptomatic and supportive

(103) •
Zinc poisoning may occur as a result of three distinct processes:

(1) ingestion of toxic amounts of zinc

with food or drink; (2) direct skin contact with zinc or
zinc salts; (3) inhalation of fairly high concentrations of
freshly formed zinc oxide fumes (103).
Metal fume fever caused by the inhalation of zinc
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oxide fumes results in fever II malaise., and depression and a
cough which may become violent enough to induce vomiting,
excessive salivation, headache, and possible gastrointestinal
symptoms, though this is disputed.

Other aspects observed

are leukocytosis and chilling about eight hours after exposure (103).
Zinc apparently antagonizes either the absorption of
copper from the gastrointestinal tract or the utilization
of copper within the tissues or both.

Under conditions of

excess zinc, there is a breakdown in the mechanism of hematopoiesis and of formation of active. cytochrome oxidase and
ca talase, for both of. which adequate concentrations of available copper are necessary (96).
The level of zinc toxicity has not been determined in
humans.

However, the dose of. the salt, zinc sulfate, causing

emesis is approximately two grams.

Paries in .his wound heal-

ing study, was able to give his patients 220 mg zinc sulfate
T.I~D.

with impunity, in fact, actual beneficial effects (71).
11.

Miscellaneous

On the basis of some research in zinc deficient chicks,
an etiology for the development of rheumatoid arthritis could
be postulated (62).
Increased amounts of zinc are excreted in the urine
of patients with acute intermittent porphyria.

Fecal and

urinary porphyrins extracted in this condition apparently are

zinc complexes.

Zinc may act as a detoxirying agent in-

creasing the water solubility and urinary excretion or the
porphyrins (67).
Zinc content or mouse dystrophic gastronemious is
2.2 times that or normal (38).
Red cell zinc content in patients with pernicious
anemia is increased over normal. but reverted to normal
levels arter therapy (99).
Serum zinc concentrations in acute and chronic inrections (pneumonia, bronchitis, erisepelas, pyelonephritis)
are decreased below the range or normal values and are restored to normal levels with recovery (76) •.
Urinary zinc excretion is increased in acute rheumatic rever (67).
/

Serum zinc levels are increased above normal in
hyperthyroidism, hypertension, polycythemia vera, and eosinophilia, and following the administration or adrenaline,
thyroxine, thyrotropic hormone, theraputic X-irradiation
and experimentally induced hyperthemia (76).
Increased urinary excretion of zinc has been round in
hypertensive patients and during the administration of EDTA.
The parenteral administration or disodium calcium EDTa to
hypercholesterolemic patients not only produced a signiricant raIl in serum

cholesterollevels~

but induced a simul-

taneous tenfold increase in urinary zinc levels, whereas
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oral administration produced no consistent changes
in the cholesterol levels but more than a fourfold increase
in urinary zinc (76).
Evidence seems to indicate that one of the actions
of zinc is in the area of protein and nucleic acid synthesis.
Zinc deficiency in some micro-organisms interferes with the
synthesis of RNA and thus secondarily inhibits the synthesis
of DNA and other proteins (77).
CHAPTER VI
CONCLUSION
Much remains to be elucidated concerning the role
zinc plays in metabolism of humans.

The essentiallity of

zinc for life has been established and that it is active as
the metal moiety of a number of important enzymes.

Zinc

participates in enzymatic pathways o£ metabolism through its
close association with these enzymes.
The metabolic role of zinc is wide reaching.

Homeo-

static derangement of zinc produces many different manifestations in plants, animals, and man.
Although dietary intake and biologic stores of zinc
may be adequate during health, evidence is accumulating that
a deficiency may occur rapidly in the chronically ill or
severely traumatized patient.

Possibly, supplemental zinc

should be provided patients who are nutritionally depleted,

or who have been subjected to severe trauma.
To

~ully

understand the underlying basis and patho-

logy of zinc deficiency and zinc metabolism, it will require
continued research to identify the specific areas of metabolic dysfunction and to further delineate observations in
the composition and struc.ture of. the specific substances
which function in association with zinc.
In conclusion, rather than being a micronutrient, or
"trace element", as zinc is so often labeled, I submit that
zinc is actually a,major element absolutely essential to
h~~n

life, but is only found in small quantities in the body

due to the finely tuned role it plays in the overall scheme
of human metabolism.

There are many unanswered questions

remaining to be studied and answered before the complete
role of zinc in the body can be fully known.
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